Gunther Tutein

Gunther Tutein is managing partner at Spirit Link. His drive is to improve marketing in the healthcare sector through the strategic use of digital channels. For him, a good day is when he has been able to give a healthcare client a new impetus for their marketing, with which they sweep the target group off their feet. For him, the future belongs to strategies that optimally combine digital and classic marketing channels.

Let's talk
"Next" arrowHybrid collaboration - which settings work and which don't
21.7.2021
//
Gunther Tutein

Hybrid collaboration - which settings work and which don't

A snapshot of our experiences. Everything used to be simple. We sat in the office and met in meeting rooms. Then COVID-19 came along and meetings took place online. Not an easy world ("you're mooched") but at least everyone was in the same place: at home. Now that some are back in the office while many are at home, it gets complicated: "hybrid meetings" become necessary.

"Next" arrowAfter one year, we are switching off WhatsApp and Messenger again for this blog. Read why here.
25.11.2019
//
Gunther Tutein

After one year, we are switching off WhatsApp and Messenger again for this blog. Read why here.

Our blog lives primarily from SEO traffic and the email newsletter. A year ago, we added WhatsApp and Messenger as additional channels. As a reader, you could receive every single article as a push on your smartphone. The service ran via WhatsBroadcast/Messengerpeople.

"Next" arrowWhat the industry is talking about right now
2.4.2019
//
Gunther Tutein

What the industry is talking about right now

What is currently keeping the industry most busy? We got a good overview at the Healthcare Marketing Barcamp. A review by Gunther Tutein.

"Next" arrowComment: On the maturity of marketing automation
17.12.2018
//
Gunther Tutein

Comment: On the maturity of marketing automation

When it comes to marketing automation, there are many expectations in the market. At conferences, many stories can be heard à la "what we do" or "our claim is". If you take a closer look, a very sober picture emerges of the real applications that can be found in the market today...

"Next" arrowChatbots - useful or just a gimmick?
23.7.2018
//
Gunther Tutein

Chatbots - useful or just a gimmick?

Almost all of you have heard of them, some already use them regularly. We are talking about chatbots or simply bots, technical dialogue systems that respond automatically to text or voice input without direct human intervention. Three variants are briefly explained here.

"Next" arrowWhat are the marketing opportunities for cooperation with the patient app Ada?
13.3.2018
//
Gunther Tutein

What are the marketing opportunities for cooperation with the patient app Ada?

The patient app Ada is currently much discussed. It analyses symptoms and gives a diagnosis suggestion. This again shifts a bit more decision-making away from the doctor to the patient. How do we want to deal with this application from a marketing perspective - and what opportunities are there?

"Next" arrowMarketing automation - a comic
29.6.2017
//
Gunther Tutein

Marketing automation - a comic

A comic about marketing automation, which is now common practice in healthcare communication. If you're serious, you buy software that can make a big difference. And sometimes they just make coffee with it.

"Next" arrowHealthcare Marketing Barcamp 2017
20.4.2017
//
Gunther Tutein

Healthcare Marketing Barcamp 2017

We decided to venture into a new format for our annual exchange of healthcare marketing communication industry representatives: the Barcamp - and it was a complete success right from the first time.

"Next" arrowHealth 2.0 - the 4 trends from the European conference
31.7.2016
//
Gunther Tutein

Health 2.0 - the 4 trends from the European conference

Start-ups and investors met again this year in Barcelona so that the most successful approaches can be further promoted. What are the trends among them?

"Next" arrowThe other day at eyeforpharma (multichannel comic)
20.6.2016
//
Gunther Tutein

The other day at eyeforpharma (multichannel comic)

And today something completely different, a comic. Inspired by the many multichannel sessions at the last eyeforpharma.

"Next" arrowCurrent beliefs in multi-channel marketing
23.3.2016
//
Gunther Tutein

Current beliefs in multi-channel marketing

Multichannel marketing was once again one of the TOP topics at this year's eyeforpharma in Barcelona. What is there to tell about the topic after all these years? Convictions follow, primarily presented by Amgen, Novartis...

"Next" arrowExamples of artificial intelligence in everyday medical life
23.11.2015
//
Gunther Tutein

Examples of artificial intelligence in everyday medical life

The topic of artificial intelligence actually sounds like science fiction at first. It sounds like films, books about the future ... it doesn't sound like everyday medicine as we know it today. Precisely because the topic seems so far away, I would like to introduce three companies that deal with it.

"Next" arrowPhysician search as a permitted offer by Pharma and MedTech? - A legal appraisal
15.9.2015
//
Gunther Tutein

Physician search as a permitted offer by Pharma and MedTech? - A legal appraisal

From a marketing point of view, it is an exciting offer on a patient website: I offer a doctor search and as a result the patient only finds doctors who also use my own product. Of course, I also say this openly.

"Next" arrowThe target group in person: a rheumatologist at the university clinic
23.3.2015
//
Gunther Tutein

The target group in person: a rheumatologist at the university clinic

In this series, we present to you how individual doctors or other medical professionals perceive the industry's marketing measures. Today it is the turn of Axel Hueber, MD, PhD, rheumatologist at the University Hospital Erlangen.

"Next" arrowHealth 2.0 - actual innovations are coming
22.7.2015
//
Gunther Tutein

Health 2.0 - actual innovations are coming

As every year, the Health 2.0 conference is an impressive show of the upheavals happening in the health market right now. In this article we give a quick overview of the most important developments and present the most impressive start-ups or business ideas.

"Next" arrowThe target group in person: a rheumatologist at the university clinic
11.7.2016
//
Gunther Tutein

The target group in person: a rheumatologist at the university clinic

In this series, we present to you how individual doctors or other medical professionals perceive the industry's marketing measures. Today it is the turn of Axel Hueber, MD, PhD, rheumatologist at the University Hospital Erlangen.

"Next" arrowSelf-testing wearables: on possible additional benefits in patient care
3.3.2015
//
Gunther Tutein

Self-testing wearables: on possible additional benefits in patient care

The topics "quantify yourself", "track yourself" or "wearables" are currently popping up in many corners. In this article I want to show what added value the current generation of devices could offer patients in studies or care programmes.

"Next" arrowPatientus - Potentials of the Online Doctor's Consultation for Marketing
21.2.2015
//
Gunther Tutein

Patientus - Potentials of the Online Doctor's Consultation for Marketing

When new services are created in the healthcare market, we as an agency usually ask ourselves: Is this something that can represent added value for our clients? This was also the case with Patientus, the online doctor's consultation. We discussed the potential of this service with the managing director Nicolas Schulwitz.

"Next" arrowThe target group in person: a radiologist at the university hospital
20.1.2015
//
Gunther Tutein

The target group in person: a radiologist at the university hospital

In this new series, we present how individual doctors or other medical professionals perceive the industry's marketing measures. We start with Dr Tobias Baumann, until recently senior physician in the Department of Radiology at the University Hospital Freiburg.

"Next" arrowHow do I drive traffic to my professional pages?
26.2.2014
//
Gunther Tutein

How do I drive traffic to my professional pages?

As an agency, we are often asked what is the best way to drive traffic to websites for medical professionals. Where do I actually reach the doctors? Do they actually log on to the site via DocCheck?

"Next" arrowMini survey: Young doctors and medical students on the web
13.6.2013
//
Gunther Tutein

Mini survey: Young doctors and medical students on the web

Every now and then, we too, as a strongly digital agency, try to match our digital worldview with the actual of doctors and the doctors growing up. Here is another brief comparison. 74 medical students and 23 young doctors were interviewed.

"Next" arrowMulti-channel - an example project as an overview
24.2.2013
//
Gunther Tutein

Multi-channel - an example project as an overview

Let's take an example drug with a turnover of 50 million € per year. Since access to customers is becoming increasingly difficult for the sales force, the sales forecast is negative. How can a multi-channel project achieve a positive ROI in this situation? The article offers an insight.

"Next" arrowOur Round Table 2012
23.10.2012
//
Gunther Tutein

Our Round Table 2012

Our Round Table has now been around for ten years. We always invite a group of about 30 people from the marketing of medical technology and pharmaceuticals to present their projects and experiences to each other.

"Next" arrowBrief introduction: washabich.de - Start-up with real added value for patients
23.8.2012
//
Gunther Tutein

Brief introduction: washabich.de - Start-up with real added value for patients

washabich.de - a highly acclaimed start-up that creates real added value for patients by translating the doctor's findings into understandable German. How does it work and what can we learn from it in marketing? A short article.

"Next" arrowIs there online exchange among doctors? What happens in the communities?
27.1.2012
//
Gunther Tutein

Is there online exchange among doctors? What happens in the communities?

Although specialist communities are being discussed everywhere, there is not a single doctor in my circle of acquaintances who actually uses such a medical community.And so I went and looked at some communities. What about Springer, Esanum, Coliquio, Researchgate....?

"Next" arrowPharma Social Media Awards (Dosie)
7.10.2011
//
Gunther Tutein

Pharma Social Media Awards (Dosie)

It's that time again, the Dosie Awards have been presented. What is it about? It's about social media, it's about pharma, and the winner is the one who gets the most votes. The awards are always interesting because they once again put a good spotlight on the industry.

"Next" arrowMarket Access: Should pharmaceutical companies publish health economic data online?
23.6.2011
//
Gunther Tutein

Market Access: Should pharmaceutical companies publish health economic data online?

Of course, market access involves much more than dealing with health economic data. However, these data now play a more important role in the decision-making process, at which price a drug is approved, which volumes are approved, etc. The question I would like to address briefly is: What role does the internet currently play in this for payers in Germany? The question I would like to address briefly is: What role does the internet currently play for payers in Germany?

"Next" arrowHow good is your project? Three Healthcare Awards winners for comparison
7.3.2011
//
Gunther Tutein

How good is your project? Three Healthcare Awards winners for comparison

Is my project good? How does it stand when I compare it with the competition? In this article, I will take you through three quite different projects and provide an explanation of what makes them stand out.